Most cited papers from Morgan Adams Foundation

Morgan Adams Foundation

What are the most cited papers from Morgan Adams Foundation?

The most cited paper from Morgan Adams Foundation is "Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1" (Daniel J. Klionsky et al., 2021), with 2,743 citations. Next come "Targeting autophagy in cancer" (2,635) and "Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients" (434).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 25 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Daniel J. Klionsky et al. · Autophagy Open access2,930 authors	2 Jan 2021	2,743
2	Targeting autophagy in cancer Jean M. Mulcahy Levy, Christina G. Towers, Andrew M. Thorburn · Nature reviews. Cancer ReviewOpen access	28 Jul 2017	2,635
3	Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients Jean M. Mulcahy Levy, Andrew M. Thorburn · Cell Death and Differentiation Open access	13 Dec 2019	434
4	Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma Gregor Hütter, Johanna Lena Theruvath, Claus Moritz Graef et al. · Proceedings of the National Academy of Sciences Open access	2 Jan 2019	261
5	Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors Jean M. Mulcahy Levy, Shadi Zahedi, Andrea M. Griesinger et al. · eLife Open access	16 Jan 2017	178
6	Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma Kent A. Riemondy et al. · Neuro-Oncology Open access	30 May 2021	154
7	Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells Anandani Nellan, Christopher Rota, Robbie G. Majzner et al. · Journal for ImmunoTherapy of Cancer Open access	30 Apr 2018	142
8	Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous Craniopharyngioma Andrew M. Donson et al. · Journal of Neuropathology & Experimental Neurology Open access	27 Jul 2017	133
9	Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques Anandani Nellan, Cynthia M. Lester McCully, Rafael Cruz Garcia et al. · Blood Open access	28 Jun 2018	120
10	Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma Shannon Coy, Rumana Rashid, Jia‐Ren Lin et al. · Neuro-Oncology Open access	Mar 2018	115
11	scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy Jennifer Karin Ocasio et al. · Nature Communications Open access	20 Dec 2019	111
12	Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma Suchismita Mohanty, Ketan Yerneni, Johanna Lena Theruvath et al. · Cell Death and Disease Open access	15 Jan 2019	103
13	Single-Cell RNA Sequencing of Childhood Ependymoma Reveals Neoplastic Cell Subpopulations That Impact Molecular Classification and Etiology Austin E. Gillen, Kent A. Riemondy, Vladimir M. Amani et al. · Cell Reports Open access	Aug 2020	100
14	Targeting IL-6 Is a Potential Treatment for Primary Cystic Craniopharyngioma Sydney T. Grob, David M. Mirsky, Andrew M. Donson et al. · Frontiers in Oncology Open access	21 Aug 2019	95
15	BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway Adam L. Green et al. · Oncogene Open access	16 Dec 2019	92
16	Contemporary Biological Insights and Clinical Management of Craniopharyngioma John Richard Apps, Hermann Lothar Muller, Todd Cameron Hankinson et al. · Endocrine Reviews Open access	27 Dec 2022	89
17	Pediatric high‐grade glioma: moving toward subtype‐specific multimodal therapy Hannah V. Chatwin, Joselyn Cruz Cruz, Adam L. Green · FEBS Journal	2 Feb 2021	75
18	Specific expression of PD‐L1 in RELA‐fusion supratentorial ependymoma: Implications for PD‐1‐targeted therapy Davis A. Witt, Andrew M. Donson, Vladimir M. Amani et al. · Pediatric Blood & Cancer Open access	19 Jan 2018	74
19	Adamantinomatous craniopharyngioma: moving toward targeted therapies Astrid C. Hengartner, Eric W. Prince, Trinka Vijmasi et al. · Neurosurgical FOCUS Open access	2020	73
20	A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma Andrew B. Lassman, Patrick Yung Wen, Martin J. van den Bent et al. · Clinical Cancer Research Open access	2 Nov 2021	72
21	The Inflammatory Milieu of Adamantinomatous Craniopharyngioma and Its Implications for Treatment Ros Whelan, Eric W. Prince, Ahmed Gilani et al. · Journal of Clinical Medicine Open access	14 Feb 2020	72
22	Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics—CheckMate 908 Ira J. Dunkel, François Doz, Nicholas K. Foreman et al. · Neuro-Oncology Open access	9 Feb 2023	71
23	MiR‐1253 exerts tumor‐suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7‐H3) Ranjana Kumari Kanchan, Naveenkumar Perumal, Pranita Atri et al. · Brain Pathology Open access	7 Mar 2020	70
24	Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG Ilango Balakrishnan et al. · Cell Reports Open access	Oct 2020	69
25	Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma John A. DeSisto et al. · Nature Communications Open access	20 Sep 2021	67
26	Inhibition of MYC attenuates tumor cell self‐renewal and promotes senescence in SMARCB1‐deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo Irina N. Alimova, Angela M. Pierce, Etienne P. Danis et al. · International Journal of Cancer Open access	19 Sep 2018	65
27	New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs Senthilnath Lakshmanachetty, Joselyn Cruz-Cruz, Eric Hoffmeyer et al. · Cells Open access	14 Apr 2021	62
28	Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas Pooja Panwalkar et al. · Science Translational Medicine Open access	6 Oct 2021	61
29	Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors Jessica A. Lake, Andrew M. Donson, Eric W. Prince et al. · Pediatric Blood & Cancer Open access	8 Oct 2019	57
30	Review of xanthomatous lesions of the sella Bette Kay Kleinschmidt-DeMasters, Kevin O. Lillehei, Todd Cameron Hankinson · Brain Pathology Open access	25 Feb 2017	56
31	Some implications for the study of the doctor-patient interaction: Power, structure, and agency in the works of Howard Waitzkin and Arthur Kleinman Gregory Fernando Pappas · Social Science & Medicine	1990	56
32	Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B Maximilian Y. Deng et al. · Nature Communications Open access	20 Sep 2021	55
33	Pediatric versus adult meningioma: comparison of epidemiology, treatments, and outcomes using the Surveillance, Epidemiology, and End Results database Roy Dudley, Michelle R. Torok, Sarah Randall et al. · Journal of Neuro-Oncology	9 Mar 2018	52
34	Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysis Eric W. Prince et al. · Neuro-Oncology Open access	9 Feb 2024	51
35	Mapping pediatric brain tumors to their origins in the developing cerebellum Konstantin Okonechnikov et al. · Neuro-Oncology Open access	2 Aug 2023	49
36	A novel PLK1 inhibitor onvansertib effectively sensitizes MYC-driven medulloblastoma to radiotherapy Dong Wang, Bethany L. Veo, Angela M. Pierce et al. · Neuro-Oncology Open access	3 Sep 2021	46
37	Super Elongation Complex as a Targetable Dependency in Diffuse Midline Glioma Nathan A. Dahl, Etienne P. Danis, Ilango Balakrishnan et al. · Cell Reports Open access	Apr 2020	46
38	Transcriptional control of DNA repair networks by CDK7 regulates sensitivity to radiation in MYC-driven medulloblastoma Bethany L. Veo, Etienne P. Danis, Angela M. Pierce et al. · Cell Reports Open access	Apr 2021	45
39	Individual-patient prediction of meningioma malignancy and survival using the Surveillance, Epidemiology, and End Results database Jeremy T. Moreau, Todd Cameron Hankinson, Sylvain Baillet et al. · npj Digital Medicine Open access	30 Jan 2020	43
40	Deconvoluting Mechanisms of Acquired Resistance to RAF Inhibitors in BRAFV600E-Mutant Human Glioma Karisa C. Schreck, Andrew Morin, Guisheng Zhao et al. · Clinical Cancer Research Open access	25 Aug 2021	42
41	Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors Lindsey Marie Hoffman, Elizabeth A. Richardson, Ben Ho et al. · Neuro-Oncology Open access	2 Mar 2020	41
42	Targetable molecular alterations in congenital glioblastoma Ahmed Gilani, Andrew M. Donson, Kurtis D. Davies et al. · Journal of Neuro-Oncology	24 Dec 2019	40
43	Response assessment in paediatric intracranial ependymoma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group Holly Lindsay, Maura Massimino, Shivaram Avula et al. · The Lancet Oncology	25 Jul 2022	39
44	Microglia and monocyte-derived macrophages drive progression of pediatric high-grade gliomas and are transcriptionally shaped by histone mutations James L. Ross, Montserrat Puigdelloses-Vallcorba, Gonzalo Piñero et al. · Immunity Open access	11 Oct 2024	37
45	Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations Holly J. Roberts et al. · Acta Neuropathologica Open access	18 Oct 2023	37
46	Population-Based Analysis of Demographic and Socioeconomic Disparities in Pediatric CNS Cancer Survival in the United States Robert Fineberg, Shadi Zahedi, Megan Eguchi et al. · Scientific Reports Open access	12 Mar 2020	37
47	Intracranial Ewing sarcoma: four pediatric examples Michael J. Yang, Ros Whelan, Jennifer R. Madden et al. · Child s Nervous System Open access	28 Dec 2017	37
48	MRI-guided focused ultrasound blood–brain barrier opening increases drug delivery and efficacy in a diffuse midline glioma mouse model Payton J. Martinez, Genna Nault, Jenna Steiner et al. · Neuro-Oncology Advances Open access	2023	36
49	Targeting fibroblast growth factor receptors to combat aggressive ependymoma Daniela Lötsch et al. · Acta Neuropathologica Open access	27 May 2021	35
50	Effect of early-stage autophagy inhibition in BRAFV600E autophagy-dependent brain tumor cells Shadi Zahedi, Brent E. Fitzwalter, Andrew Morin et al. · Cell Death and Disease Open access	12 Sep 2019	35

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.